Evidence map›Paper›PMID 33204753›Full record

ArticleOpen forum infectious diseases2020

Trends in Antibiotic Consumption and Resistance in France Over 20 Years: Large and Continuous Efforts but Contrasting Results.

Jean Carlet, Vincent Jarlier, Jacques Acar, Olivier Debaere, Patrick Dehaumont, Bruno Grandbastien, Pierre Le Coz, Gerard Lina, Yves Pean, Claude Rambaud and 5 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Jean CarletWorld Alliance Against Antibiotic Resistance (WAAAR), Paris, France.
Vincent JarlierLaboratory of Bacteriology and Hygiene, Assistance Publique-Hopitaux de Paris, Pitie-Salpetriere Hospital, Paris, France.
Jacques AcarPierre and Marie Curie University, Paris, France.
Olivier DebaereMinistry of Agriculture, Paris, France.
Patrick DehaumontMinistry of Agriculture, Paris, France.
Bruno GrandbastienFrench Society of Hospital Hygiene (SF2H), Hospital Prevention Unit, University Hospital, Lausanne, Switzerland.
Pierre Le CozHealth Industries Education Program, Paris, France.
Gerard LinaInfectious Agents Institute, Croix Rousse Hospital and International Centre for Research in Infectious Diseases, INSERM, Lyon University, Lyon, France.
Yves PeanNational Observatory of the Epidemiology of the Bacterial Resistance to Antibiotics (ONERBA), Paris, France.
Claude RambaudLe Lien, Paris, France.
France RoblotFrench Society of Infectious Diseases (SPILF), University of Poitiers, Poitiers, France.
Jérôme SalomonMinistry of Health and Solidarity, Paris, France.
Benoit SchlemmerFrench National Plans against Antibacterial Resistance, Paris-Diderot University, Sorbonne Paris-Cité, Paris, France.
Pierre TattevinFrench Society of Infectious Diseases, Rennes University, Rennes, France.ORCID 0000-0003-3617-5411
Benoit ValletMinistry of Health and Solidarity, Paris, France.
CNR de la Résistance aux Antibiotiques · FRMinistère de l'Agriculture et de la Souveraineté alimentaire · FRMinistère des Solidarités et de la Santé · FRSorbonne Université · FRDélégation Paris 7 · FRInserm · FRParisTech · FRUniversité de Poitiers · FR

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundAntimicrobial resistance (AMR) is a serious threat to humanity. This paper describes the French efforts made since 2001 and presents data on antimicrobial consumption (AC) and AMR.

methodsWe gathered all data on AC and AMR recorded since 2001 from different national agencies, transferred on a regular basis to standardized European data on AC and resistance in both humans and animals.

resultsAfter a large information campaign implemented in France from 2001 to 2005 in humans, AC in the community decreased significantly (18% to 34% according to the calculation method used). It remained at the same level from 2005 to 2010 and increased again from 2010 to 2018 (8%). Contrasting results were observed for AMR. The resistance of

conclusionsAntibiotic consumption decreased significantly in France after a large public campaign from 2001 to 2005, but this positive effect was temporary. The effect on AMR varied according to the specific microorganism: The effect was very impressive for gram-positive cocci, variable for gram-negative bacilli, and moderate for

Indexed as

antibiotic consumptionantibiotic resistanceantibioticsbacterial transmissiongram-negative bacilligram-positive cocci

Identifiers

PMID33204753
PMCPMC7651446
OpenAlexW3105852818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.